Literature DB >> 17706599

Mass spectroscopic phosphoprotein mapping of Ral binding protein 1 (RalBP1/Rip1/RLIP76).

Mikael C Herlevsen1, Dan Theodorescu2.   

Abstract

RalBP1, a multifunctional protein implicated in cancer cell proliferation, radiation and chemoresistance, and ligand dependent receptor internalization, is upregulated in bladder cancer and is a downstream effector of RalB, a GTPase associated with metastasis. RalBP1 can be regulated by phosphorylation by protein kinase C (PKC). No studies have comprehensively mapped RalBP1 phosphorylation sites or whether RalB affects these. We identified 14 phosphorylation sites of RalBP1 in human bladder carcinoma UMUC-3 and embryonic kidney derived 293T cells. The phosphorylated residues are concentrated at the N-terminus. Ten of the first 100 amino acids of the primary structure were phosphorylated. Nine were serine residues, and one a threonine. We evaluated the effect of RalB overexpression on RalBP1 phosphorylation and found the largest change in phosphorylation status at S463 and S645. Further characterization of these sites will provide novel insights on RalBP1 biology, its functional relationship to RalB and possible avenues for therapeutic intervention.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17706599      PMCID: PMC2679903          DOI: 10.1016/j.bbrc.2007.07.163

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  26 in total

1.  RalA and RalB: antagonistic relatives in cancer cell migration.

Authors:  Gary Oxford; Charles R Owens; Brian J Titus; Tonia L Foreman; Mikael C Herlevsen; Steven C Smith; Dan Theodorescu
Journal:  Cancer Res       Date:  2005-08-15       Impact factor: 12.701

Review 2.  14-3-3 proteins as potential oncogenes.

Authors:  Guri Tzivion; Vinita Singh Gupta; Ludmila Kaplun; Vitaly Balan
Journal:  Semin Cancer Biol       Date:  2006-04-01       Impact factor: 15.707

3.  The role of PKCalpha and RLIP76 in transport-mediated doxorubicin-resistance in lung cancer.

Authors:  Sharad S Singhal; Sushma Yadav; Jyotsana Singhal; Kenneth Drake; Yogesh C Awasthi; Sanjay Awasthi
Journal:  FEBS Lett       Date:  2005-08-29       Impact factor: 4.124

4.  Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells.

Authors:  Kian-Huat Lim; Kevin O'Hayer; Stacey J Adam; S Disean Kendall; Paul M Campbell; Channing J Der; Christopher M Counter
Journal:  Curr Biol       Date:  2006-12-19       Impact factor: 10.834

Review 5.  Ral GTPases: corrupting the exocyst in cancer cells.

Authors:  Jacques H Camonis; Michael A White
Journal:  Trends Cell Biol       Date:  2005-06       Impact factor: 20.808

6.  Determinants of differential doxorubicin sensitivity between SCLC and NSCLC.

Authors:  Sharad S Singhal; Dilki Wickramarachchi; Jyotsana Singhal; Sushma Yadav; Yogesh C Awasthi; Sanjay Awasthi
Journal:  FEBS Lett       Date:  2006-03-24       Impact factor: 4.124

7.  Epsin binds to the EH domain of POB1 and regulates receptor-mediated endocytosis.

Authors:  K Morinaka; S Koyama; S Nakashima; T Hinoi; K Okawa; A Iwamatsu; A Kikuchi
Journal:  Oncogene       Date:  1999-10-21       Impact factor: 9.867

8.  Competitive control of independent programs of tumor necrosis factor receptor-induced cell death by TRADD and RIP1.

Authors:  Lixin Zheng; Nicolas Bidere; David Staudt; Alan Cubre; Jan Orenstein; Francis K Chan; Michael Lenardo
Journal:  Mol Cell Biol       Date:  2006-05       Impact factor: 4.272

9.  RLIP76, an effector of the GTPase Ral, interacts with the AP2 complex: involvement of the Ral pathway in receptor endocytosis.

Authors:  V Jullien-Flores; Y Mahé; G Mirey; C Leprince; B Meunier-Bisceuil; A Sorkin; J H Camonis
Journal:  J Cell Sci       Date:  2000-08       Impact factor: 5.285

10.  RLIP76 (RalBP1) is an R-Ras effector that mediates adhesion-dependent Rac activation and cell migration.

Authors:  Lawrence E Goldfinger; Celeste Ptak; Erin D Jeffery; Jeffrey Shabanowitz; Donald F Hunt; Mark H Ginsberg
Journal:  J Cell Biol       Date:  2006-09-11       Impact factor: 10.539

View more
  12 in total

1.  The RLIP76 N-terminus binds ARNO to regulate PI 3-kinase, Arf6 and Rac signaling, cell spreading and migration.

Authors:  Seunghyung Lee; Jeremy G T Wurtzel; Lawrence E Goldfinger
Journal:  Biochem Biophys Res Commun       Date:  2014-10-30       Impact factor: 3.575

Review 2.  RLIP76 Targeted Therapy for Kidney Cancer.

Authors:  Sharad S Singhal; Jyotsana Singhal; James Figarola; David Horne; Sanjay Awasthi
Journal:  Pharm Res       Date:  2015-05-29       Impact factor: 4.200

Review 3.  RLIP76 Inhibition: A Promising Developmental Therapy for Neuroblastoma.

Authors:  Sharad S Singhal; Lokesh Nagaprashantha; Preeti Singhal; Sulabh Singhal; Jyotsana Singhal; Sanjay Awasthi; David Horne
Journal:  Pharm Res       Date:  2017-04-06       Impact factor: 4.200

4.  Crucial Role of RLIP76 in Promoting Glycolysis and Tumorigenesis by Stabilization of HIF-1α in Glioma Cells Under Hypoxia.

Authors:  Qi Wang; Chi Zhang; Junle Zhu; Lei Zhang; Huairui Chen; Jun Qian; Chun Luo
Journal:  Mol Neurobiol       Date:  2022-08-23       Impact factor: 5.682

Review 5.  RLIP76: A novel glutathione-conjugate and multi-drug transporter.

Authors:  Sharad S Singhal; Sushma Yadav; Cherice Roth; Jyotsana Singhal
Journal:  Biochem Pharmacol       Date:  2008-10-15       Impact factor: 5.858

Review 6.  RLIP76: a versatile transporter and an emerging target for cancer therapy.

Authors:  Rit Vatsyayan; Poorna Chandra Rao Lelsani; Sanjay Awasthi; Sharad S Singhal
Journal:  Biochem Pharmacol       Date:  2010-01-25       Impact factor: 5.858

7.  Src phosphorylation of RhoGDI2 regulates its metastasis suppressor function.

Authors:  Yimin Wu; Konstadinos Moissoglu; Hong Wang; Xuejiao Wang; Henry F Frierson; Martin A Schwartz; Dan Theodorescu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-03-25       Impact factor: 11.205

8.  RLIP76 regulates Arf6-dependent cell spreading and migration by linking ARNO with activated R-Ras at recycling endosomes.

Authors:  Jeremy G T Wurtzel; Seunghyung Lee; Sharad S Singhal; Sanjay Awasthi; Mark H Ginsberg; Lawrence E Goldfinger
Journal:  Biochem Biophys Res Commun       Date:  2015-10-20       Impact factor: 3.575

9.  Emerging treatments in lung cancer - targeting the RLIP76 molecular transporter.

Authors:  Lawrence E Goldfinger; Seunghyung Lee
Journal:  Lung Cancer (Auckl)       Date:  2013

Review 10.  RLIP76: A Structural and Functional Triumvirate.

Authors:  Jasmine Cornish; Darerca Owen; Helen R Mott
Journal:  Cancers (Basel)       Date:  2021-05-04       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.